Non-Hodgkin Lymphoma

Videos

Triplet Combination Appears Well-Tolerated, Safe for DLBCL

06/18/2020

Charles Herbaux, MD, MSc, discusses results from the phase 2 GATA study, which evaluated the efficacy and safety of obinutuzumab plus atezolizumab and venetoclax for relapsed/refractory DLBCL.

Charles Herbaux, MD, MSc,...

06/18/2020

Oncology

Conference Insider

PET-CT Status After First Line Immunochemotherapy Prognostic for Survival in FL

06/17/2020

Achieving a PET-CT complete metabolic response after first line immunochemotherapy is strongly associated with improved survival outcomes in FL.

Achieving a PET-CT complete...

06/17/2020

Oncology

$Glofitamab Demonstrates Strong Efficacy, Manageable Safety in Relapsed/Refractory NHL$

Videos

Glofitamab Demonstrates Strong Efficacy, Manageable Safety in Relapsed/Refractory NHL

06/17/2020

Michael Dickinson, MBBS (Hons), D.Med Sci, FRACP, FRCPA, discusses the results of a phase 1 dose escalation study of glofitamab in relapsed/refractory NHL.

Michael Dickinson, MBBS (Hons),...

06/17/2020

Oncology